Clinical Trial Update: Comparison of Vasodilator Response of Inhaled Epoprostenol and Inhaled Nitric Oxide [Phase 4]

View source ↗

Summary

Phase 4 trial comparing vasodilator responses of inhaled epoprostenol vs inhaled nitric oxide in pulmonary hypertension; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension

Drugs mentioned

• Inhaled nitric oxide (nitric oxide)
• inhaled epoprostenol (epoprostenol)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Pulmonary Hypertension | Phase 4 | Status: COMPLETED